ORIC Maintained by Stifel -- Price Target Raised to Alpha Vantage · GuruFocus · · AI-summarised by FinFlash
Stifel analyst Laura Prendergast maintained a "Buy" rating on ORIC Pharmaceuticals and raised the price target to Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · GuruFocus · · AI-summarised by FinFlash
Stifel analyst Laura Prendergast maintained a "Buy" rating on ORIC Pharmaceuticals and raised the price target to Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context